Jarrod Adkison, M.D.
Radiation Oncology Physician in Dothan, Alabama.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,141 in Radiation Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Jarrod Adkison, M.D. reported a CMS MIPS final score of 97.6/100 - above the 83.5 national average - and filed 2,226 Medicare Part D claims in 2024.
- 97.6/100
- MIPS score · +14 vs avg
- 2K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥84th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jarrod Adkison, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1790719318), first enumerated 07/10/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,226 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 97.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$878.06 in reported industry payments (33 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1790719318 · Radiation Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1790719318
- ENUM-LEGACY 2006
- TAX-MID 6K Radiation Oncology
- MIPS-ELITE 97.6/100
- RX-MID 2,226
- BOOK-THIN 76 in Alabama
- PHOTO-FINISH Daniel Arsenault, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Adkison · this p…
Adkison · this provider
97.6 MIPS pts
- Kaleigh Doke, MD…
Kaleigh Doke, MD
97.6 MIPS pts
- Daniel Arsenault…
Daniel Arsenault, MD
97.6 MIPS pts
- David Binder, MD…
David Binder, MD
97.6 MIPS pts
- Mackenzie Daly, …
Mackenzie Daly, MD
97.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jarrod Adkison, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jarrod Adkison, M.D. sits
This provider among radiation oncology physician peers
Across the 1,834 radiation oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jarrod Adkison, M.D. writes more Part D claims than 100% of them and scores higher on MIPS quality than 83% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one radiation oncology physician peer from a representative sample of 60; the gold marker is Jarrod Adkison, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Jarrod Adkison, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jarrod Adkison, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Alabama
How Radiation Oncology Physician compares to other specialties among Alabama providers
Radiation Oncology Physician ranks #88 among Alabama's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Alabama provider total, by primary NUCC taxonomy. The highlighted bar is Radiation Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Jarrod Adkison, M.D.'s 2023 MIPS final score plotted against the Radiation Oncology Physician national average
- MIPS Final Score
- 97.6/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Radiation Oncology Physician US NPIs
97.6/100 MIPS final score - 14.1 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Radiation Oncology Physician. Quality dim: 86.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1790719318 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/10/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jarrod Adkison, M.D.'s current license status, disciplinary history, and board certifications with the Alabama Board of Medical Examiners in Alabama before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1790719318 is the unique 10-digit identifier CMS uses to link Adkison across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jarrod Adkison, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$878
Largest payer
Sumitomo Pharma America, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 3,011.9
- Total Day Supply
- 73,925
- Generic Drug Cost
- $39K
- Opioid Claims
- 299 (13.4% rate)
- Antibiotic Claims
- 229
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 2.01
- Gender Split
- 41% female / 59% male
- Age Distribution
- <65: 44, 65-74: 259, 75-84: 201, 85+: 39
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jarrod Adkison, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
248 claims
- Ondansetron Hcl
Ondansetron Hcl
137 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
132 claims
- Triamcinolone Acet… 91
Triamcinolone Acetonide
91 claims
- Tramadol Hcl 75
Tramadol Hcl
75 claims
- Orgovyx 65
Orgovyx
65 claims
- Lidocaine Hcl Visc… 64
Lidocaine Hcl Viscous
64 claims
- Prednisone 59
Prednisone
59 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 248 |
| Ondansetron Hcl | 137 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 132 |
| Triamcinolone Acetonide | 91 |
| Tramadol Hcl | 75 |
| Orgovyx Relugolix | 65 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 64 |
| Prednisone | 59 |
| Doxycycline Hyclate | 55 |
| Alprazolam | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How Jarrod Adkison, M.D. fits within the Radiation Oncology Physician landscape nationally.
Jarrod Adkison, M.D.'s 2,226 claims are above the specialty average of 135.
Nationwide Radiation Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Adkison, both outside Alabama so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Radiation Oncology Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Adkison.
One of 76 Radiation Oncology Physician providers enrolled in Alabama, 5 are shown here.
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jarrod Adkison, M.D.'s specialty? ▼
How much does Jarrod Adkison, M.D. prescribe under Medicare Part D? ▼
What is Jarrod Adkison, M.D.'s Medicare quality score? ▼
Where is Jarrod Adkison, M.D. located? ▼
What is Jarrod Adkison, M.D.'s NPI number? ▼
Does Jarrod Adkison, M.D. prescribe opioids? ▼
How many Radiation Oncology Physician providers are there in the US? ▼
What drugs does Jarrod Adkison, M.D. prescribe most often? ▼
Does Jarrod Adkison, M.D. accept Medicare? ▼
How can I verify Jarrod Adkison, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.